Olivia C Ciampa

A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma

M. Parker, Z. Nagy, O. Sangfelt, 2021, Oncogene.

Withaferin A activates TRIM16 for its anti-cancer activity in melanoma

Z. Nagy, G. Marshall, B. Cheung, 2020, Scientific Reports.

Drugging MYCN oncogenic signalling through the MYCN-PA2G4 binding interface.

M. Fischer, A. Oberthuer, M. Parker, 2019, Cancer research.

Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.

J. Fletcher, G. Marshall, M. Wong, 2020, International journal of cancer.